CDK12 and uterine carcinoma: ATM, BRCA, CHECK2, and CDK12 mutations were frequent in cholangiocarcinoma (Supplementary Table S8, N = 34) with similar results in uterine carcinoma (Supplementary Table S9, N = 57), though the significance of these results is limited by small sample sizes.